XENE
Companies
NASDAQ
Xenon Pharmaceuticals Inc.
Health Care
$31.89
-$7.31 (-18.65%)
Price Chart
Overview
About XENE
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
Market Cap
$2.8B
Volume
53.4M
Avg. Volume
37.3M
P/E Ratio
-8.828652
Dividend Yield
0.00%
Employees
247.0
Company Information
Latest News for XENE
Risk & Correlation Analysis
Market Correlation
0.64
Low Correlation
Volatility
Medium (0.36)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, XENE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.8B
Volume53.4M
P/E Ratio-8.83
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025